A.T.A. Fazekas
- Reproductive Medicine top 1%
- Hypothalamic control of reproductive hormones 6
- Ovarian function and disorders 4
- Endometriosis Research and Treatment 4
-
- Hormonal and reproductive studies 10
- Growth Hormone and Insulin-like Growth Factors 4
- Obstetrics and Gynecology top 5%
- Uterine Myomas and Treatments 3
-
- Prostate Cancer Treatment and Research 9
- Genetics top 10%
-
- Sexual Differentiation and Disorders 5
A.T.A. Fazekas
33 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 87
- Reproductive Medicine 527
- Endocrinology, Diabetes and Metabolism 570
- Obstetrics and Gynecology 190
- Pulmonary and Respiratory Medicine 609
- Genetics 217
Countries citing papers authored by A.T.A. Fazekas
This map shows the geographic impact of A.T.A. Fazekas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.T.A. Fazekas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.T.A. Fazekas more than expected).
Fields of papers citing papers by A.T.A. Fazekas
This network shows the impact of papers produced by A.T.A. Fazekas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.T.A. Fazekas. The network helps show where A.T.A. Fazekas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A.T.A. Fazekas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 39 | |
| 2 | 1986 | 3 | |
| 3 | 1985 | 19 | |
| 4 | 1985 | 1 | |
| 5 | 1985 | 84 | |
| 6 | 1984 | 31 | |
| 7 | 1984 | 156 | |
| 8 | 1984 | 2 | |
| 9 | 1984 | 8 | |
| 10 | 1984 | 0 | |
| 11 | 1984 | 1 | |
| 12 | 1983 | 19 | |
| 13 | 1983 | 22 | |
| 14 | 1983 | 29 | |
| 15 | New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen. | 1982 | 212 |
| 16 | 1975 | 11 | |
| 17 | [Studies on the glucocorticoid control of zinc metabolism]. | 1975 | 1 |
| 18 | 1975 | 3 | |
| 19 | 1975 | 5 | |
| 20 | 1974 | 7 |
About A.T.A. Fazekas
A.T.A. Fazekas is a scholar working on Reproductive Medicine, Endocrinology, Diabetes and Metabolism and Medical Laboratory Technology, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hormonal and reproductive studies (10 papers), Prostate Cancer Treatment and Research (9 papers), Hypothalamic control of reproductive hormones (6 papers), Sexual Differentiation and Disorders (5 papers), Ovarian function and disorders (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Endometriosis Research and Treatment (4 papers) and Uterine Myomas and Treatments (3 papers). The work is most often cited by research in Reproductive Medicine (527 citations), Endocrinology, Diabetes and Metabolism (570 citations) and Obstetrics and Gynecology (190 citations). A.T.A. Fazekas has collaborated with scholars based in Canada, Germany and Hungary. Frequent co-authors include Fernand Labrie, André Lemay, Rodolphe Maheux, Nacia Faure, J.M. Husson, A. Bèlanger, A. Dupont, G. Tolis, Jean‐Pierre Raynaud and G. Monfette. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.